Phagos is a biotechnology company pioneering the development of precision phage therapy to address the global crisis of antibiotic resistance. Founded in Paris, France, Phagos focuses on leveraging bacteriophages—natural viruses that target and destroy specific bacteria—as a sustainable, targeted alternative to antibiotics. The company has developed a proprietary platform that combines synthetic biology, AI-driven phage selection, and rapid diagnostics to create next-generation antibacterial solutions tailored to individual infections. Its applications span human and animal health, as well as agriculture and food safety. Phagos is driven by a mission to build a future where bacterial infections are treated without contributing to antibiotic resistance, enabling a safer, more sustainable world.Protecting your investments is paramount in today’s volatile market. Our risk management solutions are designed to safeguard your financial interests while maximizing potential returns. By employing a comprehensive risk assessment framework, we identify potential threats to your portfolio and implement strategies to mitigate them. Our team of experts continuously monitors market trends and adjusts your strategies accordingly, ensuring that your investments remain resilient against uncertainties. With our proactive approach, you can invest with confidence, knowing that your financial future is secure and well-managed.